6月17日,Arthritis & Rheumatology在线发表了中国科学院上海巴斯德研究所张晓明课题组完成的题为Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients with Amyopathic Dermatomyositis with Interstitial Lung Disease的研究论文,揭示了高致死性无肌病性皮肌炎(Amyopathic Dermatomyositis,ADM)的免疫学特征和预后新指标。该杂志同时配发特约述评Immune Cell Signatures to Stratify Patients with Systemic Autoimmune Diseases: a Step Towards Individualized Medicine,对该项研究成果给予高度评价,并指出免疫分层是自身免疫病患者开展个体化精准治疗的重要前提和基础。